Cargando…

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors

Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timmerman, Dennis M., Eleveld, Thomas F., Gillis, Ad J. M., Friedrichs, Carlijn C., Hillenius, Sanne, Remmers, Tessa L., Sriram, Sruthi, Looijenga, Leendert H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583723/ https://www.ncbi.nlm.nih.gov/pubmed/34769213 http://dx.doi.org/10.3390/ijms222111774

Ejemplares similares

Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2022)

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
por: Lobo, João, et al.
Publicado: (2020)

DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours
por: de Boer, Carmela M, et al.
Publicado: (2012)

Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report
por: Hulsker, Caroline C. C., et al.
Publicado: (2021)

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males
por: Spiller, Cassy M., et al.
Publicado: (2020)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

XIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality
por: Lobo, João, et al.
Publicado: (2019)

Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
por: Lobo, João, et al.
Publicado: (2019)

Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
por: Dorssers, Lambert C. J., et al.
Publicado: (2019)

Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis
por: Elzinga-Tinke, Jenny E, et al.
Publicado: (2015)

Mediastinal Germ Cell Tumor with Testicular Microlithiasis
por: Mulla, Nasser
Publicado: (2021)

Expression of Intermediate Filaments in the Developing Testis and Testicular Germ Cell Cancer
por: Camacho-Moll, Maria E., et al.
Publicado: (2022)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

Comparative Analyses of Liquid-Biopsy MicroRNA371a-3p Isolation Protocols for Serum and Plasma
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Analysis of a mouse germ cell tumor model establishes pluripotency-associated miRNAs as conserved serum biomarkers for germ cell cancer detection
por: Loehr, Amanda R., et al.
Publicado: (2023)

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
por: van Agthoven, Ton, et al.
Publicado: (2017)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors
por: Eckert, Dawid, et al.
Publicado: (2008)

VASA mRNA (DDX4) detection is more specific than immunohistochemistry using poly- or monoclonal antibodies for germ cells in the male urogenital tract
por: Boellaard, Willem P.A., et al.
Publicado: (2017)

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
por: Lobo, João, et al.
Publicado: (2021)

TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors
por: Bacon, Jack V W, et al.
Publicado: (2022)

Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples
por: Lobo, João, et al.
Publicado: (2021)

Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors
por: Killian, J. Keith, et al.
Publicado: (2016)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Genome Wide DNA Methylation Profiles Provide Clues to the Origin and Pathogenesis of Germ Cell Tumors
por: Rijlaarsdam, Martin A., et al.
Publicado: (2015)

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
por: Bakardjieva-Mihaylova, Violeta, et al.
Publicado: (2019)

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
por: Singh, Ratnakar, et al.
Publicado: (2019)

c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
por: Scheri, Katia Corano, et al.
Publicado: (2018)

Familial Male-limited Precocious Puberty (FMPP) and Testicular Germ Cell Tumors
por: Kooij, Cezanne D, et al.
Publicado: (2022)

Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
por: Scheri, Katia Corano, et al.
Publicado: (2018)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Genomic copy number and expression patterns in testicular germ cell tumours
por: McIntyre, A, et al.
Publicado: (2007)

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours
por: Murray, Matthew J, et al.
Publicado: (2016)

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
por: van Agthoven, Ton, et al.
Publicado: (2016)

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
por: Gutekunst, Matthias, et al.
Publicado: (2011)

Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology
por: Looijenga, Leendert H. J., et al.
Publicado: (2019)

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors
por: Lobo, João, et al.
Publicado: (2021)

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
por: Burger, H., et al.
Publicado: (1998)

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
por: Lobo, João, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15f56j83b2nqojkvs272uqf7km